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I N T R O D U C T I O N
Acute aortic syndrome is a modern term that describes the acute presentation of 
patients with characteristic “aortic” pain caused by one of the life-threatening thoracic 
aortic conditions including aortic dissection, intramural hematoma and penetrating 
atherosclerotic ulcer. This entity involves acute lesions of the aorta involving the tunica 
media and can be distinguished by their etiopathogenesis and characteristic appearance 
using various diagnostic imaging modalities. Recent advances in imaging techniques 
and therapeutic interventions have increased awareness of these pathological condi-
tions and emphasized the importance of early diagnosis and treatment. Each of these 
syndromes also shares the Stanford classification that defines the location and extent 
of aortic involvement. Stanford type A begins in the ascending aorta, while type B 
originates distal to the left subclavian artery to involve the descending thoracic aorta. 
This classification system is popular since it directs different management strategies 
and correlates with patient prognosis. Aortic dissections can also be classified as acute 
or chronic, depending on whether the dissection is less or greater than 2 weeks old.
Classic aortic dissections are the most common cause of acute aortic syndromes 
(70%).1 Aortic dissection is the most common aortic catastrophe occurring two to 
three times more frequently than abdominal aortic rupture.
A )  T Y P E  A  A O R T I C  D I S S E C T I O N
Acute aortic dissection type A (AADA) remains a life threatening medical con-
dition requiring emergent surgical therapy.1,2 Despite improvements in diagnostics, 
medical therapy and surgical technique, patient mortality and morbidity remain high. 
Standard treatment in the setting of AADA is the replacement of the ascending aorta 
with resection of the entry site, often in combination with an open distal anastomosis 
or hemiarch replacement, during a period of circulatory arrest with implementation 
of adjunct neuroprotective strategies such as cerebral perfusion and hypothermia. 
However, this treatment leaves the downstream aorta untouched and a residual dis-
section membrane remains in up to 70% of patients treated for AADA. The risk of 
progressive dilation with possible need for aortic re-intervention over the long -term 
remains. Due to this risk, a more aggressive approach with complete arch replacement 
and possible stenting of the proximal descending aorta via an antegrade approach has 
been adopted by a number of clinical institutions worldwide to better obliterate the 
false lumen and thus reduce the incidence of late aortic complications. Other groups, 
however, have demonstrated an increased risk of mortality and morbidity when exacic 
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aorta with a suitable form of frozen elephant trunk.tensive 
surgery involving the aortic arch and the downstream aorta 
is implemented, thus recommending a more conservative ap-
proach to the treatment of AADA patients. 
Analysis of the German Registry for Acute Aortic Dissec-
tion type A (GERAADA) gave the opportunity to compare 
the surgical outcomes of patients with AADA treated by total 
arch replacement and those of hemiarch replacement, with 
respect to early mortality, and onset of new neurological and 
malperfusion deficit. In view of these data, it may be concluded 
that more extensive treatment with total arch replacement 
and possibly adjunct therapy of the descending aorta can 
be performed in the setting of the AADA at an acceptable 
operative risk comparable to the standard treatment with 
replacement of the ascending aorta. Immediate postoperative 
complications are higher, however 30-day mortality and the 
onset of new neurological and malperfusion deficit show no 
significant difference. In the absence of pre-existing neurologi-
cal deficits, subgroup analysis demonstrates a higher mortality 
for patients treated with total arch replacement. Long-term 
results are presently not obtained by the registry data, and 
are clearly necessary to justify the necessity of possible aortic 
re-intervention for patients treated for AADA by the differ-
ing surgical approaches. According to the current Mayo clinic 
perspective, a surgeon should deal with the arch in the manner 
that is safest in his hands at the time of the acute event, as long 
as he is prepared to address the thor
B )  T Y P E  B  A O R T I C  D I S S E C T I O N
Acute type B aortic dissection (identified within 2 weeks 
of symptom onset ), as described using the Stanford classifica-
tion, involves the aorta distal to the left subclavian artery and 
accounts for 25%-40% of all aortic dissections.3 The traditional 
treatment paradigm of medical management for uncompli-
cated acute type B dissection and open surgical intervention 
for early or late complications of type B dissection is currently 
undergoing a period of evolution as a result of the influence of 
minimally invasive thoracic endovascular aortic repair options. 
Thoracic endovascular aortic repair (TEVAR) has replaced open 
surgical repair as the preferred treatment for complicated 
acute type B aortic dissection, and may also prove beneficial 
for prophylactic repair of uncomplicated acute type B dissec-
tion for high-risk patients. A number of studies have suggested 
several subsets of high risk uncomplicated patients who may 
benefit from early TEVAR. Specific predictors of early or late 
adverse events identified in multiple studies include an initial 
aortic diameter >4 cm with a patent false lumen, an initial 
false lumen diameter >22 mm in the proximal descending 
aorta, recurrent/refractory pain or hypertension, or intramural 
hematoma with development of a penetrating atherosclerotic 
ulcer in the proximal descending aorta. 
I N T R A M U R A L  H E M A T O M A
Aortic intramural hematoma (IMH) account for up to 
20% of all cases of acute aortic syndromes and represent a 
variant dissection characterized by the absence of an intimal 
flap, reentrant tear, or double channel with false lumen flow. 
Intramural hematomas often occur in patients with severe 
atherosclerotic disease in which penetrating aortic ulcers or 
atherosclerotic plaques rupture causing intimal injury with 
blood entering the media.
T Y P E  A  I M H
The recommended treatment for patients with type A 
IMH is prompt surgical intervention. Proximal IMH are inde-
pendently associated with potential progression to dissection, 
aneurysm and rupture as well as poor clinical outcomes. The 
risk of a nonsurgical approach to type A IMH demonstrates an 
early mortality of 55% compared with 8% following surgical 
repair. However, for patients with significant comorbidities 
and uncomplicated type A IMH (no dissection or intimal tear, 
thickness less than 11 mm, aortic diameter less than 50 mm), 
medical treatment with follow-up imaging and timed surgical 
intervention has been recommended.
T Y P E  B  I M H
The management of IMH involving the descending aorta 
(type B) is similar to that recommended for type B dissec-
tions. The current literature supports medical management. 
However, if complications arise (ulceration, expansion and 
dilatation), endograft placement may be considered although 
limited data exists. Endografts may cause erosion of the intima 
during the acute phase. IMH of the descending aorta have been 
associated with an in-hospital mortality rate of 10%, similar 
to that of type B aortic dissection, further emphasizing the 
importance of correct diagnosis and proper treatment.
P E N E T R A T I N G  
A T H E R O S C L E R O T I C  U L C E R
The term penetrating atherosclerotic ulcer (PAU) 
describes a condition in which ulceration of an atheroscle-
rotic lesion penetrates the intima and extends into the media 
eroding the inner elastic layer of the aortic wall. Penetrating 
atherosclerotic ulcers are focal lesions most often located in 
the descending thoracic aorta, which correlates with a greater 
disease burden in that region. These patients tend to be older 
with severe systemic atherosclerosis but without connective 
tissue diseases. Multiple PAUs are often found in a single 
patient. Imaging of PAU most often reveals extensive athero-
sclerosis with severe intimal calcification and plaque. A crater 
or extravasation of contrast is often visualized. 
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There are multiple important factors to identify when 
diagnosing PAU. One must determine the number (single or 
multiple), location (type A or B), and associated complica-
tions (IMH, dissection, pseudoaneurysm, and rupture). Type 
A PAU should be treated surgically. Medical therapy is indi-
cated in stable patients with type B PAU. Very few centers 
advocate any surgical intervention in uncomplicated type B 
patients because there is a high risk of organ failure and poor 
prognosis due to the high likelihood of extensive atheroscle-
rotic disease. For patients with symptomatic or progressive 
disease, focal PAU in the descending aorta are ideal targets 
for endograft placement. Criteria for endograft placement in 
the acute setting include pain and rupture and in the chronic 
case indications include recurrent pain, aortic diameter greater 
than 55 mm, and increase in size greater than 10 mm per year.
C O N C L U S I O N
Significant advances have been made in the diagnosis 
and management of acute aortic dissections over the past 
two decades, including surgical techniques for the ascending 
aorta dissections and percutaneous repair techniques for the 
descending aorta syndromes. These advancements have led 
to a better understanding of aortic pathology and led to the 
discovery of variants that are collectively termed acute aortic 
syndrome. Despite a persistent level of uncertainty in the di-
agnosis and management of this lethal disorder, advances are 
being made and patient outcomes are improving.
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